An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations.
about
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
An 8-week, open-label, dose-fi ...... iency from GRN gene mutations.
@en
An 8-week, open-label, dose-fi ...... iency from GRN gene mutations.
@nl
type
label
An 8-week, open-label, dose-fi ...... iency from GRN gene mutations.
@en
An 8-week, open-label, dose-fi ...... iency from GRN gene mutations.
@nl
prefLabel
An 8-week, open-label, dose-fi ...... iency from GRN gene mutations.
@en
An 8-week, open-label, dose-fi ...... iency from GRN gene mutations.
@nl
P2093
P2860
P50
P1476
An 8-week, open-label, dose-fi ...... iency from GRN gene mutations.
@en
P2093
Anna Karydas
Chiara Corbetta-Rastelli
Jesse Brown
Kirsten E Fleischmann
Laura L Mitic
Lauren Herl Martens
Mary Koestler
Mehrdad Shamloo
P2860
P304
P356
10.1016/J.TRCI.2017.08.002
P577
2017-09-12T00:00:00Z